These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12828670)

  • 1. Continuous infusion.
    Schulman S
    Haemophilia; 2003 Jul; 9(4):368-75. PubMed ID: 12828670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience.
    Campbell PJ; Rickard KA
    Aust N Z J Med; 1998 Aug; 28(4):440-5. PubMed ID: 9777111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
    Bona RD; Weinstein RA; Weisman SJ; Bartolomeo A; Rickles FR
    Am J Hematol; 1989 Sep; 32(1):8-13. PubMed ID: 2502914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of coagulation factors: current opinion.
    Batorova A; Martinowitz U
    Curr Opin Hematol; 2006 Sep; 13(5):308-15. PubMed ID: 16888434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B.
    Martinowitz UP; Schulman S
    Acta Haematol; 1995; 94 Suppl 1():35-42. PubMed ID: 7571993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of coagulation factors.
    Batorova A; Martinowitz U
    Haemophilia; 2002 May; 8(3):170-7. PubMed ID: 12010406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 8. Needles and needleless devices for infusion of anti-haemophilic factor concentrate: impact on protein structure and function.
    Prabhu S; Kazarian T; Hakobyan N; Jabbar A; Dunham T; Valentino LA
    Haemophilia; 2006 Jan; 12(1):58-61. PubMed ID: 16409176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of coagulation factor concentrates during intensive treatment.
    Holme PA; Tjønnfjord GE; Batorova A
    Haemophilia; 2018 Jan; 24(1):24-32. PubMed ID: 28873263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors.
    Leissinger C; Gringeri A; Antmen B; Berntorp E; Biasoli C; Carpenter S; Cortesi P; Jo H; Kavakli K; Lassila R; Morfini M; Négrier C; Rocino A; Schramm W; Serban M; Uscatescu MV; Windyga J; Zülfikar B; Mantovani L
    N Engl J Med; 2011 Nov; 365(18):1684-92. PubMed ID: 22047559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose and response in haemophilia--optimization of factor replacement therapy.
    Srivastava A
    Br J Haematol; 2004 Oct; 127(1):12-25. PubMed ID: 15384973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion therapy in haemophilia.
    Varon D; Martinowitz U
    Haemophilia; 1998 Jul; 4(4):431-5. PubMed ID: 9873771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.
    Dingli D; Gastineau DA; Gilchrist GS; Nichols WL; Wilke JL
    Haemophilia; 2002 Sep; 8(5):629-34. PubMed ID: 12199670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma-derived factor VIII.
    Takedani H
    Haemophilia; 2010 Sep; 16(5):740-6. PubMed ID: 20398072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of coagulation factor products.
    Stachnik JM; Gabay MP
    Ann Pharmacother; 2002 May; 36(5):882-91. PubMed ID: 11978168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections.
    Bidlingmaier C; Deml MM; Kurnik K
    Haemophilia; 2006 May; 12(3):212-7. PubMed ID: 16643203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose and outcome of care in haemophilia--how do we define cost-effectiveness?
    Fischer K; Van den Berg HM; Thomas R; Kumar S; Poonnoose P; Viswabandya A; Mathews V; Kavitha ML; Bhattacharji S; Srivastava A
    Haemophilia; 2004 Oct; 10 Suppl 4():216-20. PubMed ID: 15479401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies.
    Leggett PL; Doyle D; Smith WB; Culpepper W; Cooper S; Ochsner JL
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):556-60. PubMed ID: 6423912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia.
    Park YS; Shin WJ; Kim KI
    BMC Musculoskelet Disord; 2017 Aug; 18(1):356. PubMed ID: 28830476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.